GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Asiafocus Regulatory News (AAS)

Share Price Information for Abrdn Asiafocus (AAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 278.00
Bid: 278.00
Ask: 281.00
Change: 0.00 (0.00%)
Spread: 3.00 (1.079%)
Open: 278.00
High: 278.00
Low: 278.00
Prev. Close: 278.00
AAS Live PriceLast checked at -
abrdn Asia Focus is an Investment Trust

To maximise long-term total return from a portfolio made up predominantly of smaller quoted companies (with a market cap of up to approximately USD 1.5bn at the time of investment) in the economies of Asia and Australasia, ex Japan.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Directors

20 Oct 2023 07:02

RNS Number : 7365Q
abrdn Asia Focus plc
20 October 2023
 

abrdn Asia Focus plc (the "Company")

Legal Entity Identifier (LEI): 5493000FBZP1J92OQY70

 

20 October 2023

 

Directorate Update

 

Appointment of Lucy Macdonald and Davina Curling as Non Executive Directors

 

The Board of abrdn Asia Focus plc is pleased to announce the appointments of Ms Lucy Macdonald and Ms Davina Curling as independent non-executive Directors of the Company. Ms Macdonald will join the Board from the conclusion of the Annual General Meeting on 5 December 2023 and Ms Curling will join the Board with effect from 1 March 2024. 

 

Krishna Shanmuganathan, Chair, commented:

 

"To further diversify the Board's composition and deepen the bench strength on the Board with future Board succession in mind I am very pleased to announce the appointments of Lucy Macdonald and Davina Curling. Lucy has enjoyed a successful career in asset management and was, until 2020, managing director, CIO global equities at Allianz Global Investors. Lucy will bring significant investment experience to the Board. She is an experienced board director and is currently a member of the investment committee of the RNLI, a non executive council member of the Duchy of Lancaster and senior independent director of JPMorgan Global Emerging Markets Income Trust Plc. 

 

Davina has also enjoyed a successful career in asset management and was formerly managing director, head of European equities at Russell Investments. More recently Davina has consulted on projects for small companies and start-ups in the financial, manufacturing and retail sectors. Davina is a non executive director of Henderson Opportunities Trust plc, Blackrock Greater European Investment Trust plc and INVESCO Select Trust plc and is a member of the investment committee of St James's Place Wealth management. In addition Davina has agreed to become Senior Independent Director upon joining the Board next year."

 

In accordance with Listing Rule 9.6.13 (1):

 

Ms Macdonald is a director of the following publicly listed companies: JPMorgan Global Emerging Markets Income Trust Plc and IBIS VCT 1 plc (in voluntary liquidation); and has not in the last five years retired from any publicly listed companies.

 

Ms Curling is a director of the following publicly listed companies: Henderson Opportunities Trust plc, INVESCO Select Trust plc and Blackrock Greater European Investment Trust plc; and has not in the last five years retired from any publicly listed companies.

 

Neither Ms Macdonald nor Ms Curling have any interests in any of the securities of the Company.

 

In relation to the appointment of Ms Macdonald and Ms Curling, there is no additional information required to be disclosed in accordance with Listing Rules 9.6.13 (2) - (6).

 

For further information, please contact:

 

Charles Mearns

abrdn Holdings Limited

Company Secretary

Tel. 0131 528 4132

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFLAIELALIV
Date   Source Headline
9th Mar 202312:31 pmRNSNet Asset Value(s)
8th Mar 202311:40 amRNSNet Asset Value(s)
7th Mar 202312:15 pmRNSNet Asset Value(s)
6th Mar 20236:18 pmRNSMonth End Net Asset Value(s)
6th Mar 20233:24 pmRNSGearing disclosure
6th Mar 202312:51 pmRNSNet Asset Value(s)
3rd Mar 202312:32 pmRNSNet Asset Value(s)
2nd Mar 20231:00 pmRNSNet Asset Value(s)
28th Feb 202312:33 pmRNSNet Asset Value(s)
27th Feb 20232:04 pmRNSGearing disclosure
27th Feb 202312:36 pmRNSNet Asset Value(s)
24th Feb 20231:33 pmRNSNet Asset Value(s)
23rd Feb 202311:41 amRNSNet Asset Value(s)
22nd Feb 202311:37 amRNSNet Asset Value(s)
21st Feb 202310:59 amRNSNet Asset Value(s)
20th Feb 20231:35 pmRNSGearing disclosure
20th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 202312:34 pmRNSNet Asset Value(s)
16th Feb 202312:07 pmRNSNet Asset Value(s)
15th Feb 202311:31 amRNSNet Asset Value(s)
14th Feb 20234:07 pmRNSPortfolio disclosure
14th Feb 20234:00 pmRNSSecond Interim Dividend
14th Feb 202312:28 pmRNSNet Asset Value(s)
13th Feb 20233:48 pmRNSGearing disclosure
13th Feb 202312:30 pmRNSNet Asset Value(s)
10th Feb 202312:41 pmRNSNet Asset Value(s)
9th Feb 20233:00 pmRNSCompliance with Market Abuse Regulation
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20231:29 pmRNSNet Asset Value(s)
6th Feb 20234:04 pmRNSMonth End Net Asset Value(s)
6th Feb 20232:42 pmRNSGearing Disclosures
6th Feb 202312:09 pmRNSNet Asset Value(s)
3rd Feb 202312:23 pmRNSNet Asset Value(s)
2nd Feb 20233:57 pmRNSQuarterly disclosure
2nd Feb 20231:01 pmRNSNet Asset Value(s)
31st Jan 202312:34 pmRNSNet Asset Value(s)
30th Jan 20232:10 pmRNSGearing disclosure
30th Jan 202312:31 pmRNSNet Asset Value(s)
27th Jan 202312:09 pmRNSNet Asset Value(s)
26th Jan 202312:00 pmRNSNet Asset Value(s)
25th Jan 202312:32 pmRNSNet Asset Value(s)
24th Jan 202312:59 pmRNSNet Asset Value(s)
23rd Jan 20234:22 pmRNSGearing disclosure
23rd Jan 202312:35 pmRNSNet Asset Value(s)
20th Jan 202312:48 pmRNSNet Asset Value(s)
19th Jan 202312:43 pmRNSNet Asset Value(s)
18th Jan 20235:10 pmRNSNet Asset Value(s)
18th Jan 202310:52 amRNSPortfolio disclosure
17th Jan 202312:19 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.